Candida bracarensis Detected among Isolates of Candida glabrata by Peptide Nucleic Acid Fluorescence In Situ Hybridization: Susceptibility Data and Documentation of Presumed Infection
- 1 February 2008
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (2), 443-446
- https://doi.org/10.1128/jcm.01986-07
Abstract
Molecular taxonomic studies have revealed new Candida species among phenotypically delineated species, the best example being Candida dubliniensis . This study was designed to determine the occurrence of two new molecularly defined species, Candida bracarensis and Candida nivariensis , which are closely related to and identified as Candida glabrata by phenotypic assays. A total of 137 recent clinical isolates of C. glabrata identified by phenotypic characteristics was tested with C. bracarensis and C. nivariensis species-specific peptide nucleic acid fluorescence in situ hybridization probes. Three of 137 (2.2%) isolates were positive with the C. bracarensis probe, whereas the control strain, but none of the clinical isolates, was positive with the C. nivariensis probe. D1/D2 sequencing confirmed the identification of the three isolates as representing C. bracarensis . Clinically, one C. bracarensis isolate was recovered from a presumed infection, a polymicrobial pelvic abscess in a patient with perforated diverticulitis. The other two isolates were recovered from two adult oncology patients who were only colonized. C. bracarensis was white on CHROMagar Candida, had variable API-20C patterns that overlapped with C. nivariensis and some C. glabrata isolates, and had variable results with a rapid trehalose assay. Interestingly, an isolate from one of the colonized oncology patients was resistant to fluconazole, itraconazole, voriconazole, and posaconazole in vitro. In summary, C. bracarensis was detected among clinical isolates of C. glabrata , while C. nivariensis was not. One C. bracarensis isolate causing a presumed deep infection was recovered, and another isolate was azole resistant. Whether clinical laboratories should identify C. bracarensis will require more data.Keywords
This publication has 14 references indexed in Scilit:
- Catheter-Related Fungemia Due to Fluconazole-Resistant Candida nivariensisJournal of Clinical Microbiology, 2007
- Results from the ARTEMIS DISK Global AntifungalSurveillance Study: a 6.5-Year Analysis of Susceptibilitiesof Candida and Other Yeast Species to Fluconazole andVoriconazole by Standardized Disk Diffusion TestingJournal of Clinical Microbiology, 2005
- Phenotypic and Molecular Characterization of Candida nivariensis sp. nov., a Possible New Opportunistic FungusJournal of Clinical Microbiology, 2005
- Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and IIIJournal of Clinical Microbiology, 2005
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- Candidemia: The Impact of Antifungal Prophylaxis in a Surgical Intensive Care UnitSurgical Infections, 2003
- Phylogenetic relationships among yeasts of the ? complex? determined from multigene sequence analysesFEMS Yeast Research, 2003
- Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary InvestigatorsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Rapid Identification of Staphylococcus aureus Directly from Blood Cultures by Fluorescence In Situ Hybridization with Peptide Nucleic Acid ProbesJournal of Clinical Microbiology, 2002
- Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individualsMicrobiology, 1995